Posts Tagged ‘Popper and Co’



Welcoming Stephanie Kreml, M.D. as Newest Team Member

April 3rd, 2013
Posted by

I’m pleased to announce that Stephanie Kreml, M.D. has returned to Popper and Company, joining our core team of life science advisors as Principal.

Like all of our team members, Stephanie is committed to delivering perspective, value, and high-quality, hands-on service to clients across the life sciences spectrum.  As a practicing physician with an engineering background, Stephanie brings a unique multi-disciplinary perspective to helping life sciences companies address diverse healthcare issues.  She is an excellent addition to our existing team of experts whose operational backgrounds span clinical, technology, marketing and finance in a variety of capacities in the diagnostics, medical device, pharmaceuticals and digital health industries. Read the rest of this entry »

FacebookTwitterGoogle+Share

Tags: , , , , ,
Posted in Our News | No Comments »





Employee Devices + Mobile Healthcare Information = A Quiet, Perfect Storm

April 19th, 2012
Posted by

As the founder of the 10,000+-member Digital Health group on LinkedIn, I can’t help but see that there’s a perfect storm brewing in healthcare, and it’s one with surprisingly little turbulence. As we see more employees in healthcare (whether it’s pharma, a hospital, or device and diagnostics sales) demanding to use their personal devices on the job, we’re also seeing technology and drug developers embracing the use of mobile devices in the field. Now, the big data that traditionally was accessed only from headquarters is being downloaded, wirelessly transmitted, and read by employees across the healthcare spectrum through social networks and the Internet from the clinic, laboratory, office and road.

This is the digital revolution in healthcare: not only are Microsoft® products ceasing to become the predominant platform for healthcare employees, providers and consumers, the decisions to adopt certain technologies are being made by employees, providers, and customers (and less often by the corporate IT department). For example: Read the rest of this entry »

Tags: , , , , , ,
Posted in Our Views | 1 Comment »





Welcoming Head of Digital Health Strategy Paul Sonnier as Newest Team Member

March 13th, 2012
Posted by

I’m delighted to announce that Paul Sonnier, formerly a strategic advisor to Popper and Company, has joined our core team as Head of Digital Health Strategy.

Our core team provides diversity and expertise to resolve problems and create strategies in the health arena for our life science clients. Paul, who has recently been described as a catalyst in the wireless and mobile health field, brings his familiarity, insights and experience to our existing team of experts whose operational backgrounds span clinical, technology, marketing and finance in a variety of capacities in the diagnostics, medical device and pharmaceutical industries. Read the rest of this entry »

Tags: , , , , , ,
Posted in Our News | 2 Comments »





Meditate Your Way to Longer Telomeres; Keep Aging at Bay?

January 30th, 2012
Posted by

As part of Popper and Company’s ongoing effort to scan the health care universe and share innovative ideas and solutions with you, the 2009 Nobel Prize in Physiology or Medicine has risen to the surface. That year, Elizabeth Blackburn, Carol Greider and Jack Szostack received the prize for discovering “how chromosomes are protected by telomeres and the enzyme telomerase.”  The Nobel Laureates demonstrated that chromosomes are protected from degradation by telomeres, which sit at the ends of our chromosomes, similar to the plastic cap on the end of a shoelace. There’s a lesson here that plays on a theme that Popper and Company team members often discuss among ourselves – the role the individual plays in his or her own health and longevity.

Let me explain: The telomere protects our chromosomes from becoming tattered and damaged. The enzyme telomerase helps maintain a healthy cell. As telomerase levels and activity diminish over time, our telomeres shorten and no longer divide, our cells age and no longer function properly; they then die, and well, eventually we die. Read the rest of this entry »

Tags: , , , , , , ,
Posted in Our Views | 1 Comment »





What You Need to Know About AdvaMed 2011

September 19th, 2011
Posted by

An Interview with AdvaMed Conference Producer Ray Briscuso

In preparation for AdvaMed 2011: The MedTech Conference, we had a unique opportunity to interview Ray Briscuso, President and CEO at Life Sciences Conference Group, LLC. Each year, Briscuso works with the Advanced Medical Technology Association (AdvaMed) to produce one of the most important meetings focused on medical devices and diagnostics, and which brings together more than 1,500 key MedTech executives from companies in every sector of the industry. It is the premier conference, exhibition and partnering event for medical device, diagnostic and health information companies. In the past, internationally respected voices, such as former Presidents George Bush (Sr.) and Bill Clinton, have been featured as plenary speakers.

I am eagerly anticipating September 26-28 when AdvaMed 2011 will be held in Washington, DC. Following are some insights and highlights from our discussion with Ray about how to get the most out of this year’s event: Read the rest of this entry »

Tags: , , , , , ,
Posted in Interviews | No Comments »





Leveraging a Multi-Coastal Point of View of Life Sciences

May 17th, 2011
Posted by

Having a pulse on global trends in the biopharmaceutical industry requires a wide range of insights from experience in pharmacological research and technology development through to the core operations of large-scale and startup life science businesses. With this in mind, I’m pleased to welcome Dr. Andreas Muehler as our second strategic advisor. Dr. Muehler’s experience with preclinical and clinical development, major product launches, licensing, business development, and marketing provide him with a unique combination of technical and business perspectives.

In the United States, Dr. Muehler developed and managed multiple startup medical device and medical technology companies. Among them were 3TP LLC d/b/a CAD Sciences (White Plains, NY), a medical software company that was sold to iCAD Medical in 2008. Dr. Muehler was also President & CEO of MicroMRI Inc (Langhorne, PA), a medical device company that received FDA clearance for both hardware and software components during his tenure. Dr. Muehler has also been managing director of a German healthcare private equity fund, Palladius Healthcare GmbH in Munich, which acquired distressed medical device companies. Read the rest of Dr. Muehler’s impressive bio here. Read the rest of this entry »

Tags: , , , , , ,
Posted in Our News | No Comments »





Introducing Our First Strategic Advisor: Dr. F. John Mills

May 4th, 2011
Posted by

Today’s post is an exciting one for me as I introduce our new strategic advisor, Dr. F. John Mills. With an extensive background that includes more than 25 years at the board and executive levels of major international corporations, Dr. Mills adds profound insights to our expanding operations and provides a new resource of vital information for our clients.

It’s difficult to encapsulate his entire career in a few short paragraphs and I encourage you to review his bio in the About section of our website. In brief, Dr. Mills served for three years as corporate senior vice president and president of clinical support services for Covance, Inc., where he was responsible for a $300 million per year clinical services division that employed more than 2,000 staff members globally. Prior to that, he was based in the United Kingdom as corporate vice president for Covance’s European clinical division. Earlier in his career, Dr. Mills held senior positions in Asia and Europe with Janssen Pharmaceutica, a division of Johnson & Johnson, Inc. His expertise includes extensive knowledge of clinical research outsourcing, pharmaceutical development, and global business management. Read the rest of this entry »

Tags: , , , , , ,
Posted in Our News | No Comments »





Harnessing Change

December 13th, 2010
Posted by

According to staffers at The Scientist, “If developing interesting new technologies and products really is the lifeblood of economic health, then the life sciences industry is innovation’s beating heart.”

Are advanced technologies critical to the development of your new life science products and services, or to the companies in which you invest? If so, then you likely are aware of how quickly these technologies are changing and how hard it is to stay on top of these changes. Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | No Comments »